Clinical and Laboratory Features of Renal Dysfunction in Chronic Obstructive Pulmonary Disease Comorbid with Ischemic Heart Disease

Main Article Content

Nurullayev Bakhtiyor Azimbayevich
Turakulov Rustam Ismatullaevich

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized not only by progressive airflow obstruction but also by systemic inflammation, hypoxemia, endothelial dysfunction, and multiorgan damage. When ischemic heart disease (IHD) coexists with COPD, hypoxia, hemodynamic stress, and microcirculatory disorders reinforce one another, creating conditions for an early decline in renal function. The objective is to comparatively assess renal functional status and markers of endothelial dysfunction and systemic inflammation across COPD stages II-IV in patients with and without concomitant IHD. This comparative clinical study included 135 patients with stage II-IV COPD.

Downloads

Download data is not yet available.

Article Details

Data Availability Statement

All data supporting the findings of this study are presented in the text of the scientific work.

Section

Medicine and Pharmacy

Author Biographies

Nurullayev Bakhtiyor Azimbayevich, Tashkent State Medical University

Assistant, Department of Internal Medicine in Family Medicine

Turakulov Rustam Ismatullaevich, Tashkent State Medical University

Professor at the National Medical Center, Doctor of Medical Sciences

How to Cite

Nurullayev, B., & Turakulov, R. (2026). Clinical and Laboratory Features of Renal Dysfunction in Chronic Obstructive Pulmonary Disease Comorbid with Ischemic Heart Disease. Scientific Collection «InterConf», 309, 84–87. https://interconf.openpubarchive.com/index.php/proceeding/article/view/96

References

Liu Z., Ma Y., Ding W. Association between COPD and CKD: a systematic review and meta -analysis. Frontiers in Public Health. 2024;12:1494291. DOI: 10.3389/fpubh.2024.1494291.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117 -S314. DOI: 10.1016/j.kint.2023.10.018.

Groothof D. et al. Creatinine, cystatin C, muscle mass, and mortality: findings from a primary and replication population -based cohort. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(4):1528 -1538. DOI: 10.1002/jcsm.13511.

Boiko O., Rodionova V., Shevchenko L. Features of Kidney Function in Patients With Comorbidity of Arterial Hypertension and Chronic Obstructive Pulmonary Disease. Cureus. 2022;14(11):e31828. DOI: 10.7759/cureus.31828.